# Olumiant · 2 mg · Tabletki powlekane · 84 tabl. w blistrze perforowanym



## Poland

- **URPL** — [pl.dose-10060.org](https://pl.dose-10060.org)

## Codes

- **rpl-pack-id** — `121503`
- **eu-number** — `EU/1/16/1170/007`

## Status

- **read** — 2026-11-15T02:02:49Z

## Holder

- Eli Lilly Nederland B.V.

## Proof

Record pl:presentation:121503 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Olumiant 2 mg](https://dosidal.ai/pack/be/508240-01) — BE — same product (EU central number)
- [OLUMIANT](https://dosidal.ai/pack/cz/0219351) — CZ — same product (EU central number)
- [Olumiant](https://dosidal.ai/pack/eu/EU-1-16-1170-007) — EU — same product (EU central number)
- [OLUMIANT 2 MG FILMTABLETTA](https://dosidal.ai/pack/hu/210805365) — HU — same product (EU central number)
- [Olumiant 2 mg filmom obalené tablety](https://dosidal.ai/pack/sk/3237C) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
